NCT03161340View on ClinicalTrials.gov

Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure

PHASE2CompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

May 9, 2018

Study Completion Date

June 20, 2018

Conditions

Recurrent Implantation Failure

Interventions

DRUG

Rapamycin

Patients will take Rapamycin 2 days before IVF until 15 days after IVF

Trial Locations (2)

Unknown

Qom ACECR ART Center, Qom

Estern Azarbaijan ACECR ART center, Tabriz

All Listed Sponsors

lead

Mehdi Yousefi

OTHER

NCT03161340 - Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter